Unicycive Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.38
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.26
|
0.00
|
0.26
|
100.00%
|
|
2022-09-30
|
-0.28
|
-0.37
|
-0.09
|
-32.14%
|
|
2022-06-30
|
-0.23
|
-0.24
|
-0.01
|
-4.35%
|
|
2022-03-31
|
-0.16
|
-0.24
|
-0.08
|
-50.00%
|
|
2021-12-31
|
-0.13
|
-0.24
|
-0.11
|
-84.62%
|
|
2021-09-30
|
-0.10
|
-0.08
|
0.02
|
20.00%
|
|
2021-06-30
|
-0.11
|
-0.13
|
-0.02
|
-18.18%
|
|
2021-03-31
|
0.00
|
-0.07
|
-0.07
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.85
|
|
2021-12-31
|
-0.61
|